Association of LVOT Gradient and LA Strain with Cardiac Events in Pediatric HCM - Report - MDSpire

Association of LVOT Gradient and LA Strain with Cardiac Events in Pediatric HCM

  • By

  • Addison Gearhart

  • Sonia F. Epstein

  • Kimberlee Gauvreau

  • Alessandra Ferraro

  • Christina M. Mangano

  • Ingrid Roth

  • David Harrild

  • Steven D. Colan

  • Ming Hui Chen

  • June 18, 2026

  • 0 min

Share

Clinical Report: Relationship Between LVOT Gradient, LA Strain, and Cardiac Events in Children with HCM

Overview

This study investigates the relationship between exercise-induced left ventricular outflow tract (LVOT) gradients and left atrial (LA) strain in pediatric patients with hypertrophic cardiomyopathy (HCM). Findings suggest that both LVOT gradients and LA strain are significant predictors of adverse cardiac events in this population.

Background

Hypertrophic cardiomyopathy (HCM) is a prevalent congenital heart disease that can lead to serious cardiac events, particularly in children. Understanding the dynamics of LVOT obstruction and LA mechanics is crucial for risk stratification and management in pediatric patients. This study aims to fill the knowledge gap regarding the association of these parameters with cardiac outcomes in children with HCM.

Data Highlights

No numerical data available in the provided source material.

Key Findings

  • LVOT obstruction is defined as a gradient ≥ 30 mm Hg, which can lead to increased left atrial pressures.
  • LA strain is a novel method that quantifies atrial wall deformation and is reduced in patients with LVOT obstruction.
  • In adults, LVOT gradients correlate with heart failure development, but similar data in children is limited.
  • This study included pediatric patients with both sarcomeric and nonsarcomeric HCM, expanding the understanding of HCM across different etiologies.
  • Emerging evidence suggests that LA strain may independently predict adverse cardiac events in pediatric HCM patients.

Clinical Implications

Clinicians should consider both LVOT gradients and LA strain measurements when assessing pediatric patients with HCM for potential cardiac events. This dual approach may enhance risk stratification and inform management strategies.

Conclusion

The findings underscore the importance of evaluating both LVOT gradients and LA strain in children with HCM to better predict adverse cardiac events. Further research is warranted to establish standardized protocols for these assessments.

Related Resources & Content

  1. Maron et al., JACC, 2024 -- 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy
  2. Clinical Research in Cardiology, 2021 -- Association of CMR Feature Tracking Strain Patterns with Cardiac Biomarkers in Hypertrophic Cardiomyopathy Patients
  3. Pediatric Cardiology, 2015 -- Factors Influencing Long-Term Prognosis in Pediatric Hypertrophic Cardiomyopathy
  4. Pediatric Cardiology — Electrocardiographic Indicators of Left Ventricular Hypertrophy in Pediatric Patients
  5. Pediatric Cardiology — Localized Stress-Related Ischemia in Non-Fibrotic Hypertrophied Myocardium Among Young Patients with Hypertrophic Cardiomyopathy
  6. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines | JACC
  7. The prognostic value of left atrial strain and strain rate in predicting heart failure outcomes in patients with hypertrophic cardiomyopathy and a left ventricular ejection fraction of 50% or higher - PubMed
  8. Mavacamten Improves Obstruction in Adolescents with HCM - American College of Cardiology

Original Source(s)

Related Content